Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors

Clinical trial NCT00003109 · COMPLETED

Trial details

NCT number: NCT00003109
Sponsor: Fox Chase Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-12-01
Primary completion: 2000-10-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.